Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,078 | -1,819 | -1,205 | -577 | -1,673 |
| Depreciation Amortization | 42 | 17 | 10 | 5 | 13 |
| Other Working Capital | 135 | -47 | -123 | -3 | -114 |
| Other Operating Activity | 156 | -91 | -27 | 31 | 556 |
| Operating Cash Flow | $-2,745 | $-1,940 | $-1,345 | $-545 | $-1,219 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -691 | -281 | -43 | -24 | -50 |
| Investing Cash Flow | $-691 | $-281 | $-43 | $-24 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 175 |
| Debt Repayment | N/A | N/A | N/A | N/A | -261 |
| Common Stock Issued | 3,518 | 2,951 | 2,950 | 2,998 | 4,913 |
| Financing Cash Flow | $3,518 | $2,951 | $2,950 | $2,998 | $4,827 |
| Beginning Cash Position | 3,584 | 3,584 | 3,584 | 3,584 | 26 |
| End Cash Position | 3,666 | 4,314 | 5,146 | 6,012 | 3,584 |
| Net Cash Flow | $83 | $731 | $1,563 | $2,429 | $3,558 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,745 | -1,940 | -1,345 | -545 | -1,219 |
| Capital Expenditure | -691 | -281 | -43 | -24 | -50 |
| Free Cash Flow | -3,436 | -2,221 | -1,388 | -569 | -1,269 |